This is one of the questions that breaks my heart to hear as a financial aid administrator. By the time students ask me this question, it’s too late. There’s little that I can do to help them since their eligibility has already been lost.
When most people think about a leave of absence from graduate school, they imagine students who have decided not to continue their education. That’s not the case for students in medical school.
Since I’ve started my role at a HBCU medical school, I’ve learned that stepping away from classes is rarely a sign that a student is giving up. More often, it is a necessity for students to take a leave of absence for various reasons.
Some students take a leave of absence to pursue a research fellowship, so that they can become more competitive for residency applications. Other students pursue an MPH or MBA to strengthen their resumes. Others step away because of personal issues. They may be battling cancer, navigating a pregnancy, addressing serious mental health challenges, or caring for an ill family member. These are institutionally approved leaves. The expectation for both the students and the medical school is that they will return to complete their degrees.
Unfortunately, federal financial aid policy does not always recognize that reality.
The implementation of the One Big, Beautiful Bill Act (OB3) made changes to the Graduate PLUS Loan Program. Under OB3, some students who were grandfathered into the legacy provision will continue to receive graduate plus loans if they meet certain requirements. An approved leave of absence that exceeds the 180-day limit permitted under Title IV of the Higher Education Act of 1965 (HEA) within a 12-month period permanently ends a student's eligibility for Graduate PLUS loans. Also, if students exceed the 180-day limit, they will be grandfathered into the new regulations and have new caps for their direct federal loans under OB3 once they return to school.
Congress understandably sought to reduce federal lending and taxpayer costs. In doing so, it overlooked the realities of medical education. In medical education, institutionally approved leaves are often part of the educational journey rather than a departure from it.
When students return, many will have already exhausted their remaining federal borrowing eligibility under the new loan caps. Without access to Graduate PLUS Loans, some may have no choice but to pursue private loans. Yet private lenders may deny applicants who lack established credit or a creditworthy co-signer. These requirements create financial barriers that have nothing to do with a student's academic ability or commitment to becoming a physician.
The result is a federal financial aid policy that fails to reflect how medical education works.
Research years have become increasingly common for medical students pursuing competitive specialties such as dermatology, orthopedic surgery, and plastic surgery. In today's residency environment, a research year is often not optional for students pursuing the most competitive specialties. It is an expectation. Faculty mentors frequently encourage medical students to spend a year conducting research, publishing manuscripts, networking, and presenting at national conferences because these experiences can significantly strengthen residency applications.
Ironically, students may be doing exactly what medical schools encourage them to do. They pursue a research fellowship to become more competitive in residency applications or take an approved leave to recover from illness, care for family, welcome a child, or another personal circumstance. Yet those responsible decisions may permanently cost them the federal aid they need to finish medical school.
The consequences extend far beyond individual students. Every student who is forced to delay or abandon medical school because of financing represents one less doctor available to care for patients.
No future physician should have to wonder whether taking a year long research fellowship or taking care of themselves will cost them the financial aid they need to graduate.
This is not simply a financial aid issue. It is a physician workforce issue, a healthcare access issue, and most importantly, a patient care issue.
According to a report released by Association of American Medical Colleges (AAMC) in 2024, the United States will face a shortage of 86,000 doctors by 2036. Every unnecessary financial barrier increases the risk that qualified future physicians delay or never complete their medical education. Those losses ultimately affect patients who depend on an adequate physician workforce.
Students have already invested years of their lives to practice medicine while accumulating hundreds of thousands of dollars in student loan debt. Financial aid policy should help students navigate unavoidable interruptions. It should not create new barriers that will make completing medical school even more difficult.
Congress has an opportunity to correct this problem through the Restoring College Access and Affordability Act, which would restore Graduate PLUS Loan eligibility, eliminate restrictive borrowing caps, and reinstate key borrower protections. While debates over federal lending are appropriate, students should not permanently lose access to federal financing because they took an institutionally approved leave to recover from illness, care for family, pursue research, or welcome a child.
Medical education is unlike any other graduate program, and should be treated as such. Students spend years navigating through rigorous coursework, clinical rotations, research, and patient care. Along the way, life happens. Illness interrupts training. Families need care. Children are born. Research and academic opportunities arise that produce better physicians. These are not detours from becoming a doctor. They are often part of the journey in becoming a physician.
Federal financial aid policy should reflect those realities.
Students who take institutionally approved leaves with every intention of returning should not lose the federal financing that allows them to finish medical school. If we want more physicians caring for patients, financial aid policies should not punish students for life's inevitable interruptions. Investing in their ability to return from approved absences is ultimately an investment in every patient whose life they will one day touch.
Supporting medical students through those interruptions is not simply an investment in them. It is also an investment in every patient they will serve one day.
